S&P 500   4,579.50 (+0.66%)
DOW   36,088.76 (+0.10%)
QQQ   389.47 (+1.15%)
AAPL   194.72 (+1.25%)
MSFT   368.14 (-0.18%)
META   323.78 (+1.99%)
GOOGL   136.76 (+5.18%)
AMZN   146.74 (+1.54%)
TSLA   242.19 (+1.18%)
NVDA   462.85 (+1.72%)
NIO   7.60 (-1.94%)
BABA   72.27 (+1.09%)
AMD   125.14 (+7.12%)
T   17.04 (+0.59%)
F   10.84 (+1.40%)
MU   73.82 (+0.94%)
CGC   0.71 (+1.73%)
GE   118.80 (-0.84%)
DIS   93.31 (+1.98%)
AMC   6.89 (+1.47%)
PFE   28.61 (-0.63%)
PYPL   58.92 (-1.02%)
XOM   99.96 (+0.86%)
S&P 500   4,579.50 (+0.66%)
DOW   36,088.76 (+0.10%)
QQQ   389.47 (+1.15%)
AAPL   194.72 (+1.25%)
MSFT   368.14 (-0.18%)
META   323.78 (+1.99%)
GOOGL   136.76 (+5.18%)
AMZN   146.74 (+1.54%)
TSLA   242.19 (+1.18%)
NVDA   462.85 (+1.72%)
NIO   7.60 (-1.94%)
BABA   72.27 (+1.09%)
AMD   125.14 (+7.12%)
T   17.04 (+0.59%)
F   10.84 (+1.40%)
MU   73.82 (+0.94%)
CGC   0.71 (+1.73%)
GE   118.80 (-0.84%)
DIS   93.31 (+1.98%)
AMC   6.89 (+1.47%)
PFE   28.61 (-0.63%)
PYPL   58.92 (-1.02%)
XOM   99.96 (+0.86%)
S&P 500   4,579.50 (+0.66%)
DOW   36,088.76 (+0.10%)
QQQ   389.47 (+1.15%)
AAPL   194.72 (+1.25%)
MSFT   368.14 (-0.18%)
META   323.78 (+1.99%)
GOOGL   136.76 (+5.18%)
AMZN   146.74 (+1.54%)
TSLA   242.19 (+1.18%)
NVDA   462.85 (+1.72%)
NIO   7.60 (-1.94%)
BABA   72.27 (+1.09%)
AMD   125.14 (+7.12%)
T   17.04 (+0.59%)
F   10.84 (+1.40%)
MU   73.82 (+0.94%)
CGC   0.71 (+1.73%)
GE   118.80 (-0.84%)
DIS   93.31 (+1.98%)
AMC   6.89 (+1.47%)
PFE   28.61 (-0.63%)
PYPL   58.92 (-1.02%)
XOM   99.96 (+0.86%)
S&P 500   4,579.50 (+0.66%)
DOW   36,088.76 (+0.10%)
QQQ   389.47 (+1.15%)
AAPL   194.72 (+1.25%)
MSFT   368.14 (-0.18%)
META   323.78 (+1.99%)
GOOGL   136.76 (+5.18%)
AMZN   146.74 (+1.54%)
TSLA   242.19 (+1.18%)
NVDA   462.85 (+1.72%)
NIO   7.60 (-1.94%)
BABA   72.27 (+1.09%)
AMD   125.14 (+7.12%)
T   17.04 (+0.59%)
F   10.84 (+1.40%)
MU   73.82 (+0.94%)
CGC   0.71 (+1.73%)
GE   118.80 (-0.84%)
DIS   93.31 (+1.98%)
AMC   6.89 (+1.47%)
PFE   28.61 (-0.63%)
PYPL   58.92 (-1.02%)
XOM   99.96 (+0.86%)

Cue Health Stock Price, News & Analysis (NASDAQ:HLTH)

$0.32
-0.02 (-4.48%)
(As of 10:57 AM ET)
Compare
Today's Range
$0.32
$0.34
50-Day Range
$0.27
$0.46
52-Week Range
$0.27
$3.49
Volume
20,092 shs
Average Volume
508,753 shs
Market Capitalization
$49.48 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$3.00

Cue Health MarketRank™ Stock Analysis

Analyst Rating
Hold
2.00 Rating Score
Upside/​Downside
795.5% Upside
$3.00 Price Target
Short Interest
Healthy
0.59% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
N/A
Insider Trading
N/A
Proj. Earnings Growth
Growing
From ($1.85) to ($0.99) Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.91 out of 5 stars

Medical Sector

608th out of 957 stocks

Analytical Instruments Industry

16th out of 24 stocks


HLTH stock logo

About Cue Health Stock (NASDAQ:HLTH)

Cue Health Inc., a healthcare technology company, designs and develops diagnostic platform for diagnostic tests for individuals, enterprises, healthcare providers and payors, and public health agencies. It offers Cue Integrated Care platform comprising hardware and software components, such as Cue Health Monitoring System consisting of Cue Reader, a portable and reusable reader, Cue Cartridge, a single-use test cartridge, and Cue Wand, a sample collection wand; Cue Data and Innovation Layer, a solution with cloud-based data and analytics capability; Cue Virtual Care Delivery Apps, which include Cue Health App and Cue Enterprise Dashboard; and Cue Ecosystem Integrations and Apps, a solution that allows integrations with third-party applications and sensors. The company also provides COVID-19 testing kits for the Cue Health Monitoring System The company was formerly known as Cue Inc and changed its name to Cue Health Inc. in December 2017. Cue Health Inc. was incorporated in 2010 and is headquartered in San Diego, California.

HLTH Stock Price History

HLTH Stock News Headlines

Trading Experts Call It “The Perfect Tesla Trade”
Thanks to a new discovery linked to shares of Tesla, regular folks can now target gains of 100% or more in six days or less. New research shows it’s happened 23 different times this year. The next trade is scheduled for this Thursday.
Cue Health: Q3 Earnings Insights
Cue Health Reports Third Quarter 2023 Financial Results
Trading Experts Call It “The Perfect Tesla Trade”
Thanks to a new discovery linked to shares of Tesla, regular folks can now target gains of 100% or more in six days or less. New research shows it’s happened 23 different times this year. The next trade is scheduled for this Thursday.
Cue Health (NASDAQ: HLTH)
Expert Ratings for Cue Health
See More Headlines
Receive HLTH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cue Health and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
11/08/2023
Today
12/07/2023
Fiscal Year End
12/31/2023
Next Earnings (Estimated)
3/20/2024

Industry, Sector and Symbol

Industry
Analytical instruments
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:HLTH
Fax
N/A
Employees
1,515
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$3.00
High Stock Price Target
$3.00
Low Stock Price Target
$3.00
Potential Upside/Downside
+795.5%
Consensus Rating
Hold
Rating Score (0-4)
2.00
Research Coverage
1 Analysts

Profitability

Net Income
$-194,060,000.00
Net Margins
-128.97%
Pretax Margin
-129.26%

Debt

Sales & Book Value

Annual Sales
$192.54 million
Book Value
$3.86 per share

Miscellaneous

Free Float
135,303,000
Market Cap
$51.80 million
Optionable
Optionable
Beta
1.25
10 "Recession Proof" Stocks That Will Thrive in Any Market Cover

Which stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report

Key Executives

  • Mr. Ayub K. Khattak (Age 38)
    Co-Founder, President, CEO & Chairman
    Comp: $1.06M
  • Mr. Clint Sever (Age 38)
    Co-Founder & Chief Product Officer
    Comp: $906.39k
  • Mr. Christopher K. Achar (Age 38)
    Chief Strategy Officer & Director
  • Mr. Aasim Javed (Age 39)
    CFO, Treasurer & Principal Financial Officer
  • Mr. Randall E. Pollard (Age 51)
    Controller & Principal Accounting Officer
  • Ms. Lorna Williams
    Vice President of Investor Relations
  • Ms. Erica Palsis Esq. (Age 37)
    General Counsel & Corporate Secretary
  • Ms. Eileen Sheil
    Chief Communications Officer
  • Mr. Nitin Duggal
    Chief Marketing Officer
  • Ms. Allison F. Blackwell (Age 58)
    Chief Human Resources Officer














HLTH Stock Analysis - Frequently Asked Questions

Should I buy or sell Cue Health stock right now?

1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Cue Health in the last twelve months. There are currently 1 hold rating for the stock. The consensus among Wall Street research analysts is that investors should "hold" HLTH shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in HLTH, but not buy additional shares or sell existing shares.
View HLTH analyst ratings
or view top-rated stocks.

What is Cue Health's stock price target for 2024?

1 equities research analysts have issued twelve-month price objectives for Cue Health's stock. Their HLTH share price targets range from $3.00 to $3.00. On average, they predict the company's stock price to reach $3.00 in the next twelve months. This suggests a possible upside of 795.5% from the stock's current price.
View analysts price targets for HLTH
or view top-rated stocks among Wall Street analysts.

How have HLTH shares performed in 2023?

Cue Health's stock was trading at $2.07 at the beginning of 2023. Since then, HLTH shares have decreased by 83.8% and is now trading at $0.3350.
View the best growth stocks for 2023 here
.

When is Cue Health's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, March 20th 2024.
View our HLTH earnings forecast
.

How were Cue Health's earnings last quarter?

Cue Health Inc. (NASDAQ:HLTH) issued its earnings results on Wednesday, November, 8th. The company reported ($0.42) earnings per share for the quarter, topping analysts' consensus estimates of ($0.47) by $0.05. The firm had revenue of $17.48 million for the quarter, compared to analysts' expectations of $12.32 million. Cue Health had a negative trailing twelve-month return on equity of 61.47% and a negative net margin of 128.97%.

What guidance has Cue Health issued on next quarter's earnings?

Cue Health issued an update on its fourth quarter 2023 earnings guidance on Wednesday, November, 8th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $16.00 million-$18.00 million, compared to the consensus revenue estimate of $27.45 million.

When did Cue Health IPO?

(HLTH) raised $200 million in an IPO on Friday, September 24th 2021. The company issued 12,500,000 shares at $15.00-$17.00 per share.

Who are Cue Health's major shareholders?

Cue Health's stock is owned by many different institutional and retail investors. Top institutional investors include Koch Industries Inc. (1.44%), Jacobs Levy Equity Management Inc. (0.73%), B. Riley Wealth Advisors Inc. (0.17%), Simplex Trading LLC (0.00%) and Concourse Financial Group Securities Inc. (0.00%).
View institutional ownership trends
.

How do I buy shares of Cue Health?

Shares of HLTH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

This page (NASDAQ:HLTH) was last updated on 12/7/2023 by MarketBeat.com Staff

My Account -